Sfoglia per AUTORE
NIHO S
Collezione AOU San Luigi di Orbassano
Items : 1
A phase 2 randomized study of TAS-102 versus topotecan or amrubicin in patients requiring second-line chemotherapy for small cell lung cancer refractory or sensitive to frontline platinum-based chemotherapy. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2016 Oct;100:20-23. doi: 10.1016/j.lungcan.2016.06.023. Epub 2016 Jun 27.
2016
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
Scagliotti G; Nishio M; Satouchi M; Valmadre G; Niho S; Galetta D; Cortinovis D; Benedetti F; Yoshihara E; Makris L; Inoue A; Kubota K;